IDEXX Laboratories, Inc. Revenue 2008–2025
IDEXX Laboratories, Inc. reported $4.30B of revenue for fiscal 2025. That was 10.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +59.0%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $4.30B | +10.4% |
| FY 2024 | $3.90B | +6.5% |
| FY 2023 | $3.66B | +8.7% |
| FY 2022 | $3.37B | +4.7% |
| FY 2021 | $3.22B | +18.8% |
| FY 2020 | $2.71B | +12.5% |
| FY 2019 | $2.41B | +8.8% |
| FY 2018 | $2.21B | +12.4% |
| FY 2017 | $1.97B | +10.9% |
| FY 2016 | $1.78B | +10.8% |
| FY 2015 | $1.60B | +7.8% |
| FY 2014 | $1.49B | +7.9% |
| FY 2013 | $1.38B | +6.5% |
| FY 2012 | $1.29B | +6.1% |
| FY 2011 | $1.22B | +10.4% |
| FY 2010 | $1.10B | +7.0% |
| FY 2009 | $1.03B | +0.7% |
| FY 2008 | $1.02B | — |
Source: IDEXX Laboratories, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open IDXX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
IDEXX Laboratories, Inc. reported $4.30B of revenue for fiscal 2025. That was 10.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +59.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for IDEXX Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIDEXX Laboratories, Inc. — frequently asked questions
What is IDEXX Laboratories, Inc.'s revenue?
IDEXX Laboratories, Inc. (IDXX) reported revenue of $4.30B for fiscal year 2025, per its SEC filings.
How has IDEXX Laboratories, Inc.'s revenue changed over time?
Between fiscal 2008 and 2025, IDXX's revenue grew at roughly 8.8% per year (compound annual rate), from $1.02B to $4.30B.
Where does this data come from?
Figures are computed from IDEXX Laboratories, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.